Table of contents (Vol 15, No 10)
| REVIEW |
|
| A novel therapeutic strategy of combined CAXII inhibitors and anti–PD-1 antibodies in HCC treatment |
| |
|
Hepatocellular carcinoma (HCC) is the most common histological type in primary liver cancer, which occurs predominantly in individuals with chronic liver disease or cirrhosis. HCC is the fourth leading cause of cancer-related death worldwide, and its incidence has been rising over the last 20 years globally
|
By
Rui Han
|
|
Commentary |
|
| CLINICAL OPHTHALMOLOGY PRACTICE AND EDUCATION IN AUSTRALASIAN REGION: A RECENT PERSPECTIVE |
| |
|
|
By
Rick Steves
|
|
SHORT COMMUNICATION |
|
| Possibilities for using biguanides in cancer |
| |
|
|
By
Anuvya Prare
|
|
PRE-PRINTS |
|
| Journal Thank you note |
| |
|
|
By
Rick Steves
|
| |
|
| Editor’s Note |
| |
|
|
By
Rick Steves
|
|
